Gyre Therapeutics, Inc.
GYRE
Revenue
26.77M
▲4.71M▲21.37%
3 Months ChangeAssets
152.65M
▲22.86M▲17.61%
3 Months ChangeLiabilities
23.20M
▼-2.29M▼-8.97%
3 Months ChangeFree Cash Flow
-251.00k
▼-2.90M▼-109.46%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-096159
2024-08-13
Form 8-K
ID: 0000950170-24-095687
2024-08-08
Form 8-K
ID: 0001140361-24-036404
2024-07-05
Form 8-K
ID: 0001140361-24-032511
2024-06-17
Form 8-K
ID: 0001140361-24-030348
2024-05-30
Form 8-K
ID: 0001140361-24-028106
2024-05-13
Form 10-Q
ID: 0000950170-24-058642
2024-05-09
Form 8-K
ID: 0000950170-24-056893
2024-05-08
Form 8-K
ID: 0001140361-24-024799
2024-03-26
Form 8-K
ID: 0001140361-24-015318